Hsp90 regulation of endothelial nitric oxide synthase contributes to vascular control in portal hypertension

Vijay Shah, Reiner Wiest, Guillermo Garcia-Cardena, Greg Cadelina, Roberto J. Groszmann, William C. Sessa

Research output: Contribution to journalArticle

130 Citations (Scopus)

Abstract

The molecular chaperone, heat shock protein 90 (Hsp90), acts as an intermediate in the signaling cascades leading to activation of endothelial nitric oxide synthase (eNOS). In this study, we examine the participation of this pathway in nitric oxide (NO)-dependent vasodilation in the rat mesentery in vitro. In normal animals, immunoprecipitation of eNOS from intact mesentery coimmunoprecipitates Hsp90 and, additionally, both eNOS and Hsp90 colocalize to the endothelial lining of mesenteric vessels. In the perfused mesenteric vasculature of normal animals, geldanamycin (GA), a specific inhibitor of Hsp90 signaling, attenuates ACh-dependent vasodilation but does not affect vasodilation in response to sodium nitroprusside. Next, studies were performed in animals with experimental portal hypertension induced by portal vein ligation (PVL). In PVL animals, NOS catalytic activity is markedly enhanced in mesenteric tissue and the perfused mesentery is hyporesponsive to the vasoconstrictor methoxamine (MTX). GA significantly potentiates MTX-induced vasoconstriction after PVL, thereby partially reversing the hyporeactivity to this agent exhibited in the mesenteric vasculature after PVL. These studies suggest that Hsp90 can act as a signaling mediator of NO-dependent responses in the mesenteric circulation and indicate that the excessive NO production observed in portal hypertension is mediated in part through Hsp90 signaling.

Original languageEnglish (US)
JournalAmerican Journal of Physiology - Gastrointestinal and Liver Physiology
Volume277
Issue number2 40-2
StatePublished - 1999

Fingerprint

HSP90 Heat-Shock Proteins
Nitric Oxide Synthase Type III
Portal Hypertension
Blood Vessels
Portal Vein
Mesentery
Ligation
Vasodilation
Methoxamine
Nitric Oxide
Splanchnic Circulation
Molecular Chaperones
Nitroprusside
Vasoconstrictor Agents
Vasoconstriction
Immunoprecipitation

Keywords

  • Geldanamycin
  • Portal vein ligation
  • Signal transduction

ASJC Scopus subject areas

  • Gastroenterology
  • Physiology
  • Physiology (medical)

Cite this

Hsp90 regulation of endothelial nitric oxide synthase contributes to vascular control in portal hypertension. / Shah, Vijay; Wiest, Reiner; Garcia-Cardena, Guillermo; Cadelina, Greg; Groszmann, Roberto J.; Sessa, William C.

In: American Journal of Physiology - Gastrointestinal and Liver Physiology, Vol. 277, No. 2 40-2, 1999.

Research output: Contribution to journalArticle

Shah, Vijay ; Wiest, Reiner ; Garcia-Cardena, Guillermo ; Cadelina, Greg ; Groszmann, Roberto J. ; Sessa, William C. / Hsp90 regulation of endothelial nitric oxide synthase contributes to vascular control in portal hypertension. In: American Journal of Physiology - Gastrointestinal and Liver Physiology. 1999 ; Vol. 277, No. 2 40-2.
@article{907a83fa4fbb469392e38d55dbb5a8a8,
title = "Hsp90 regulation of endothelial nitric oxide synthase contributes to vascular control in portal hypertension",
abstract = "The molecular chaperone, heat shock protein 90 (Hsp90), acts as an intermediate in the signaling cascades leading to activation of endothelial nitric oxide synthase (eNOS). In this study, we examine the participation of this pathway in nitric oxide (NO)-dependent vasodilation in the rat mesentery in vitro. In normal animals, immunoprecipitation of eNOS from intact mesentery coimmunoprecipitates Hsp90 and, additionally, both eNOS and Hsp90 colocalize to the endothelial lining of mesenteric vessels. In the perfused mesenteric vasculature of normal animals, geldanamycin (GA), a specific inhibitor of Hsp90 signaling, attenuates ACh-dependent vasodilation but does not affect vasodilation in response to sodium nitroprusside. Next, studies were performed in animals with experimental portal hypertension induced by portal vein ligation (PVL). In PVL animals, NOS catalytic activity is markedly enhanced in mesenteric tissue and the perfused mesentery is hyporesponsive to the vasoconstrictor methoxamine (MTX). GA significantly potentiates MTX-induced vasoconstriction after PVL, thereby partially reversing the hyporeactivity to this agent exhibited in the mesenteric vasculature after PVL. These studies suggest that Hsp90 can act as a signaling mediator of NO-dependent responses in the mesenteric circulation and indicate that the excessive NO production observed in portal hypertension is mediated in part through Hsp90 signaling.",
keywords = "Geldanamycin, Portal vein ligation, Signal transduction",
author = "Vijay Shah and Reiner Wiest and Guillermo Garcia-Cardena and Greg Cadelina and Groszmann, {Roberto J.} and Sessa, {William C.}",
year = "1999",
language = "English (US)",
volume = "277",
journal = "American Journal of Physiology - Renal Fluid and Electrolyte Physiology",
issn = "1931-857X",
publisher = "American Physiological Society",
number = "2 40-2",

}

TY - JOUR

T1 - Hsp90 regulation of endothelial nitric oxide synthase contributes to vascular control in portal hypertension

AU - Shah, Vijay

AU - Wiest, Reiner

AU - Garcia-Cardena, Guillermo

AU - Cadelina, Greg

AU - Groszmann, Roberto J.

AU - Sessa, William C.

PY - 1999

Y1 - 1999

N2 - The molecular chaperone, heat shock protein 90 (Hsp90), acts as an intermediate in the signaling cascades leading to activation of endothelial nitric oxide synthase (eNOS). In this study, we examine the participation of this pathway in nitric oxide (NO)-dependent vasodilation in the rat mesentery in vitro. In normal animals, immunoprecipitation of eNOS from intact mesentery coimmunoprecipitates Hsp90 and, additionally, both eNOS and Hsp90 colocalize to the endothelial lining of mesenteric vessels. In the perfused mesenteric vasculature of normal animals, geldanamycin (GA), a specific inhibitor of Hsp90 signaling, attenuates ACh-dependent vasodilation but does not affect vasodilation in response to sodium nitroprusside. Next, studies were performed in animals with experimental portal hypertension induced by portal vein ligation (PVL). In PVL animals, NOS catalytic activity is markedly enhanced in mesenteric tissue and the perfused mesentery is hyporesponsive to the vasoconstrictor methoxamine (MTX). GA significantly potentiates MTX-induced vasoconstriction after PVL, thereby partially reversing the hyporeactivity to this agent exhibited in the mesenteric vasculature after PVL. These studies suggest that Hsp90 can act as a signaling mediator of NO-dependent responses in the mesenteric circulation and indicate that the excessive NO production observed in portal hypertension is mediated in part through Hsp90 signaling.

AB - The molecular chaperone, heat shock protein 90 (Hsp90), acts as an intermediate in the signaling cascades leading to activation of endothelial nitric oxide synthase (eNOS). In this study, we examine the participation of this pathway in nitric oxide (NO)-dependent vasodilation in the rat mesentery in vitro. In normal animals, immunoprecipitation of eNOS from intact mesentery coimmunoprecipitates Hsp90 and, additionally, both eNOS and Hsp90 colocalize to the endothelial lining of mesenteric vessels. In the perfused mesenteric vasculature of normal animals, geldanamycin (GA), a specific inhibitor of Hsp90 signaling, attenuates ACh-dependent vasodilation but does not affect vasodilation in response to sodium nitroprusside. Next, studies were performed in animals with experimental portal hypertension induced by portal vein ligation (PVL). In PVL animals, NOS catalytic activity is markedly enhanced in mesenteric tissue and the perfused mesentery is hyporesponsive to the vasoconstrictor methoxamine (MTX). GA significantly potentiates MTX-induced vasoconstriction after PVL, thereby partially reversing the hyporeactivity to this agent exhibited in the mesenteric vasculature after PVL. These studies suggest that Hsp90 can act as a signaling mediator of NO-dependent responses in the mesenteric circulation and indicate that the excessive NO production observed in portal hypertension is mediated in part through Hsp90 signaling.

KW - Geldanamycin

KW - Portal vein ligation

KW - Signal transduction

UR - http://www.scopus.com/inward/record.url?scp=0032883956&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032883956&partnerID=8YFLogxK

M3 - Article

C2 - 10444461

AN - SCOPUS:0032883956

VL - 277

JO - American Journal of Physiology - Renal Fluid and Electrolyte Physiology

JF - American Journal of Physiology - Renal Fluid and Electrolyte Physiology

SN - 1931-857X

IS - 2 40-2

ER -